Jinyan Wu

Jinyan Wu

Auto-generated profile, based on publicly available information

Jinyan Wu

Yunnan Key Laboratory of Stomatology, School of Stomatology, Kunming Medical University, Kunming, China; Department of Operative Dentistry and Endodontics, The Affiliated Stomatology Hospital, Kunming Medical University, Kunming, China; Department of Operative Dentistry and Endodontics, Stomatology Hospital of Yunnan Province, Kunming, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 May 2019 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
JWJinyan Wu
Jinyan Wu
LCLingling Chen
Lingling Chen
RWRunfu Wang
Runfu Wang
ZSZhi Song
Zhi Song
ZSZongshan Shen
Zongshan Shen
ZLZhengmei Lin
Zhengmei Lin

1 March 2020 in Applied Materials Today
Verified
Journal Article
Closed access
LCLingling Chen
Lingling Chen
GLGuanqi Liu
Guanqi Liu
JWJinyan Wu
Jinyan Wu
XZXuan Zhou
Xuan Zhou
YZYiming Zhao
Yiming Zhao
Yin XiaoYin Xiao
Yin Xiao

12 February 2026 in International Dental Journal
Verified
Journal Article
Open access
SWSiyu Wang
Siyu Wang
ZDZichao Dai
Zichao Dai
LHLijun Huo
Lijun Huo
RYRongqiang Yang
Rongqiang Yang
GHGuobin Huang
Guobin Huang
JWJinyan Wu
Jinyan Wu
Apical periodontitis (AP) is a prevalent oral disease characterized by periapical tissue inflammation and alveolar bone resorption. This study investigated the inhibitory effects of human exfoliated deciduous teeth-derived exosomes (SHED-EXOs) on osteoclastogenesis, elucidated the underlying mechanisms, and evaluated their protect efficacy in AP rat models, aiming to provide novel adjunctive therapies to augment root canal treatment. In vitro, bone marrow-derived monocytes (BMMs) underwent osteoclastogenesis were cultured with graded concentrations of SHED-EXOs (0-20 μg/mL). Tartrate-resistant acid phosphatase staining and podosome belt immunofluorescence assays were performed to assess osteoclast formation. Osteoclast-related protein and gene expression were quantified. Exosomal proteomics and osteoclast transcriptomic sequencing were integrated with bioinformatic analysis to identify pivotal signalling pathways. In vivo, AP rat model were developed and received localized intrapulpal delivery of hydrogel-encapsulated SHED-EXOs. The therapeutic efficacy was evaluated through micro-CT, histological staining, and immunohistochemical analysis. SHED-EXOs concentration-dependently suppressed osteoclast formation with downregulation of NFATC1/CTSK/RANKL. Multiomics analysis revealed enrichment of PI3K-AKT signalling, and mechanistically, SHED-EXOs may inhibit osteoclastogenesis by activating PI3K-AKT pathway. In vivo, local delivery of SHED-EXOs via hydrogel significantly reduced the number of osteoclasts, decreased the expression of NFATC1 as well as RANKL, activated PI3K-AKT signalling, attenuated bone resorption, and restored periapical structure. SHED-EXOs may serve as a promising cell-free adjunctive strategy for AP, inhibiting osteoclasts potentially via PI3K-AKT activation. This study developed a novel cell-free therapeutic strategy based on SHED-EXOs to enhance the treatment efficacy for AP. SHED-EXOs effectively inhibit osteoclast activity, attenuate bone resorption, and promote periapical bone tissue repair. The underlying mechanism involves the activation of the PI3K-AKT pathway. Combined with a localized hydrogel delivery system, this strategy paves the way for innovative approaches in regenerative endodontics.